|
VIR Vir Biotechnology Inc 1706431 |
| Balance Sheet |
|
Current Assets
|
$573,739,000.00 |
|
Assets
|
$1,214,806,000.00 |
|
Current Liabilities
|
$94,961,000.00 |
|
Liabilities
|
$232,313,000.00 |
|
Equity
|
$982,493,000.00 |
|
Shares Out
|
169185671.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-9,060,000.00 |
|
Investing Cash Flow
|
$-185,307,000.00 |
| Market Analysis |
Market Cap
|
$1,558,200,029.91 |
|
Price
|
$9.21 |
|
BVPS
|
5.81 |
|
PB
|
1.59 |
|
EPS
|
0.48 |
|
PS
|
22.73 |
|
FCF
|
$-9,482,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:32 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:22 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-23 |
-0.31 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-06 |
-0.85 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-06 |
-0.80 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-05 |
-1.17 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view VIR documents filed with the SEC.
VIR Filings
Clear
